More on FBLG

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (5.0 Score)

Upcoming Events

- Earnings (7/30/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

FibroBiologics (NQ:FBLG)
Delayed: 0.77 -0.03 (3.75%)
Prev. Close $0.80  
Open$0.82 
52 Wk High$ 
52 Wk Low$ 
Day High$0.83 
Day Low$0.77 
P/E N/A  
EPS$ 
Volume160,437 

Friends, Peers and Foes (?): CGTX, COCP, PDSB, TNXP, 6XB2 (more...)

Jun 16, 2026 08:30 AM FIBROBIOLOGICS doses first patients in diabetic foot ulcer trial
Jun 16, 2026 08:30 AM FibroBiologics Advances Patient Dosing for Phase 1/2 Clinical Trial of CYWC628 for the Treatment of Diabetic Foot Ulcers
Jun 3, 2026 07:00 AM FibroBiologics begins phase 1/2 trial for diabetic foot ulcer therapy
Jun 3, 2026 07:00 AM FibroBiologics Announces First Patients Dosed in Phase 1/2 Clinical Trial Evaluating CYWC628 for the Treatment of Diabetic Foot Ulcers
May 22, 2026 08:30 AM FibroBiologics presents psoriasis data at dermatology meeting
May 22, 2026 08:30 AM FibroBiologics Presents Preclinical Data Demonstrating Durable Immunomodulation in Psoriasis at the Society for Investigative Dermatology 2026 Annual Meeting
May 18, 2026 08:30 AM FibroBiologics files patent for oral fibroblast drug delivery
May 18, 2026 08:30 AM FibroBiologics Files Patent Application for Oral Administration of Fibroblast Therapeutics
May 11, 2026 08:30 AM FibroBiologics Advancing Development of a Fibroblast Treatment for Hantavirus
May 6, 2026 07:03 AM Form 8-K FibroBiologics, Inc. For: May 05
View All Articles

Entities mentioned with FBLG

View All Entities